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Abstract
The prevalence of constipation in children is high and accounts for a large percentage of pediatric 
and pediatric gastroenterology visits. Thyroid testing is frequently ordered to evaluate constipation 
and other gastrointestinal complaints in children. We reviewed all patients with thyroid testing 
ordered by our pediatric gastroenterology division over a five-year period. We found 873 patients 
on whom thyroid testing was performed, and 56 had evidence of hypothyroidism. Nine patients 
had constipation and clinically significant hypothyroidism in this group. However, only one child 
had constipation as their sole presenting symptom. The contribution of occult hypothyroidism to 
isolated constipation in children may have been previously overestimated.
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Background
The prevalence of constipation in the pediatric population is high, approaching 30%(1). 
Approximately 5% of general pediatric outpatient visits and up to 25% of pediatric 
gastroenterology outpatient visits are for constipation(2). Textbooks and clinical practice 
guidelines from the North American Society for Pediatric Gastroenterology, Hepatology and 
Nutrition (NASPGHAN) suggest that hypothyroidism should be considered in the 
differential diagnosis of constipation(2,3). For this reason, thyroid studies are frequently 
obtained as part of standard evaluation for children with constipation, as well as for other 
problems in pediatric gastroenterology offices. Data to justify routine screening for 
hypothyroidism in constipated but otherwise healthy children, adolescents, and young adults 
are lacking.
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Studies comparing bowel movement frequency or other bowel symptoms in euthyroid, 
hypothyroid, and hyperthyroid adult patients have yielded mixed results(4, 5). Physiologic 
studies show altered anorectal function in adult patients with both hypo- and 
hyperthyroidism, but equivocal findings in bowel transit times or symptoms of 
constipation(6, 7). To our knowledge, there are no studies of the prevalence of 
hypothyroidism in pediatric patients referred for evaluation of constipation. In this study, we 
performed a retrospective chart review to determine the prevalence of unrecognized 
hypothyroidism among pediatric patients referred to our gastroenterology office who had 
thyroid testing performed.
Methods
We reviewed records for all patients with free thyroxine (free T4) or thyroid-stimulating 
hormone (TSH) tests ordered by the pediatric gastroenterology division at St. Louis 
Children’s Hospital between January 1, 2003 and January 1, 2008. Hypothyroidism was 
defined by the following laboratory values: free T4 < 0.8 ng/μL (for all ages), TSH > 10 
mIU/L (4 days – 30 days of age), or TSH > 5.5 mIU/L (older than 30 days of age). A full 
chart review was performed for all patients with thyroid testing, which included review of 
clinical presentation (i.e., indications for ordering thyroid tests, as enumerated in the 
pediatric gastroenterology consultation note), past medical history, medication history, other 
laboratory tests, radiologic evaluation, and consultation with other subspecialty services. All 
medical contact within a large, metropolitan hospital system using a single electronic 
medical record was ascertained, although no patient contact was initiated. The United States 
Department of Health and Human Services (HHS) Center for Medicare and Medicaid 
Services 2011 Clinical Laboratory Fee Schedule(8) quotes a median (mean) cost of $12.69 
($12.47) for a free T4 and $23.64 ($23.58) for a TSH. There is considerable variation in the 
cost in practice. For instance, the amount billed at our large referral children’s hospital in 
2011 was approximately $205 for TSH and $176 for free T4, whereas the amount collected 
ranged widely, from $41–102 for TSH and $35–88 for free T4. Similarly, an endocrinology 
consultation is listed by HHS as $47.18, although patients may be billed as much as $455, 
depending upon insurance coverage. In order to determine the total number of patients seen 
for constipation and slow growth over this time period, we counted all diagnostic codes 
consistent with these diagnoses. Individual chart reviews were only performed for patients 
who had thyroid testing.
The Human Research Protection Office and the Institutional Review Board at Washington 
University School of Medicine reviewed and approved this study.
Results
Patients
Free T4, TSH, or a combination of these tests was ordered 1,280 times over a 5 year period 
on a total of 873 unique patients. The mean age was 7.4 years, with a range from 10 days to 
20.5 years, and 454 (52.0%) were male. 443 children (50.7%) had constipation alone, 93 
(10.7%) had slow growth alone, 85 (9.7%) had vomiting, 80 (9.2%) had cholestasis or 
hypertransaminasemia, 40 (4.6%) had both constipation and slow growth, 57 (6.5%) had 
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another indication for the test, and 75 (8.6%) did not have an indication for the test clearly 
indicated in the consultation note. Of the 2911 unique patients with constipation (6197 total 
encounters), 483 (16.6%) had thyroid testing performed. Of the 420 children seen for slow 
growth (1215 encounters), 133 (31.7%) had thyroid testing performed. Because this is a 
retrospective analysis, the decision to test for hypothyroidism was at the discretion of the 
attending physician. We were unable to identify any change in practice patterns during the 
years evaluated.
817 of these children (93.6%) had normal thyroid tests. 56 children (6.4%) had elevated 
TSH, decreased free T4, or a combination of the two. Of the 56 abnormal tests, 40 were 
normal when repeated. 11 of these 40 had documentation indicating that TSH levels were 
drawn during an acute illness, and elevated levels were thought to be a transient 
phenomenon. For the other 29 out of 40 whose thyroid tests normalized, no documentation 
for the likely cause for the transiently abnormal TSH was given. Of the remaining 16 
children with abnormal testing that either did not normalize, or who were not retested, seven 
had known hypothyroidism prior to testing in our gastroenterology office. Nine of the 56 
abnormal thyroid tests (1.0% of all children evaluated) led to a new diagnosis of 
hypothyroidism. These results are summarized in Figure 1.
Of the nine children with newly diagnosed hypothyroidism, only seven had constipation. 
Two of the nine children were being evaluated for slow growth without constipation. Three 
children referred for constipation had trisomy 21, so thyroid function testing should have 
been part of their routine health evaluation as recommended by the American Academy of 
Pediatrics(9). Two children with constipation and newly diagnosed hypothyroidism were 
taking medications (interferon-γ for active hepatitis C and carbamazepine for epilepsy) 
known to cause secondary hypothyroidism(10, 11). In each case, hypothyroidism resolved 
after cessation of the medication. One patient with hypothyroidism was being evaluated for 
both slow growth and constipation. Thus, only one patient with newly diagnosed 
hypothyroidism presented to our office with constipation as their only recognized symptom 
of disease, as reported by parents and recorded in our office consultation.
Of those patients with normal screening results, it is unknown how many went on to develop 
hypothyroidism later in life. At the time of the review in 2009–2010, none of the patients 
with a normal TSH went on to have a repeat measurement performed by another service at 
our institution that was abnormal. It is unknown if any of these children had thyroid testing 
performed at other institutions within this time period.
Costs
The costs for laboratory testing were at least $27,400 for the 1280 blood draws ordered in 
our gastroenterology office, although they may be as high as $213,120. 18 patients were 
referred for endocrinology consultations, adding at least an additional $849 in consultation 
fees, but this may be as high as $8,190, depending upon insurance coverage. Eight of the 
referred children had hypothyroidism as a final diagnosis. Total costs billed for thyroid 
evaluation of children in our study were above and beyond the cost of the initial pediatric 
gastroenterology consultation, which was not included in this analysis. The cost of screening 
the normal patients was $18,653, but may be as high as $147,159, again depending on 
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insurance coverage. Intangible costs include repeated painful procedures (venipuncture) 
performed on 56 children, indirect costs to the family, such as transportation, childcare, and 
missed work for additional appointments, and were not included in the above calculations.
Discussion
A medical position statement from the North American Society for Pediatric 
Gastroenterology, Hepatology, and Nutrition (NASPGHAN) recommends thyroid hormone 
evaluation in children only in cases of severe, refractory constipation, and in most cases 
prior to consultation with a pediatric gastroenterologist(2). At our institution, the majority of 
patients referred to our pediatric gastroenterology clinic for constipation have already tried 
unsuccessfully to manage the condition in conjunction with their pediatrician before referral. 
These children often have had symptoms for months or years prior to referral and might 
therefore be considered refractory (although, admittedly, the degree and duration of 
constipation in all children referred to our clinic was not assessed in this study). Even among 
this selected patient population, our data suggest that thyroid function tests are unlikely to be 
abnormal in the absence of other clinical indications or risk factors for hypothyroidism, such 
as concomitant growth failure, medications, or genetic predisposition (as in trisomy 21).
This retrospective review is limited by the fact that only a small percentage of children with 
constipation who were seen in our office were tested for hypothyroidism (16.6%) and it is 
not clear if there is a difference between the tested and untested populations. For this 
analysis, we decided to assess all patients with thyroid testing, rather than patients with a 
specific diagnosis (such as constipation), to better understand the utility and practice patterns 
for thyroid hormone testing in a pediatric gastroenterology referral practice. We also did not 
make a prospective effort to identify children with recognized hypothyroidism or a family 
history of hypothyroidism, although it is anticipated that this would have been discussed as a 
routine part of our clinical care. Furthermore, it is possible that children who presented with 
constipation were identified as having hypothyroidism in their pediatrician’s office and were 
referred to endocrinology instead of to our gastroenterology office. This is likely to be 
uncommon, however, since very few of the children referred to our office for constipation 
have any thyroid testing prior to the office visit, although this was not assessed 
systematically in all patients. Despite these concerns, the very low incidence of 
hypothyroidism in our referral population suggests that testing for hypothyroidism in 
children who have constipation as their only symptom is unlikely to be helpful.
Large-scale epidemiologic studies estimate that while 4.6% of the U.S. population has 
elevated TSH, only 0.3% of the population (including children) has clinically significant 
hypothyroidism(12). Assuming that our results are representative, the likelihood of 
identifying a new case of hypothyroidism among constipated children without other clinical 
indicators (in our population, approximately 0.2%, or 1/443) is no greater than the likelihood 
of finding children with hypothyroidism by random population screening (0.3%). The yield 
of thyroid testing improves when the denominator is changed: in patients with both 
constipation and slow growth, 2.5% (1/40) were hypothyroid; in patients with slow growth 
alone, 2.2% (2/93) were hypothyroid. Thus, our data suggest that while slow growth 
increased the likelihood that a child has hypothyroidism, the presence of constipation did not 
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affect the likelihood that a child had hypothyroidism (P = 0.6, z–test, SigmaPlot 11). 
Furthermore, the financial cost of finding a single case of unrecognized hypothyroidism is 
high. Therefore, we question the wisdom of routine thyroid function testing in children with 
constipation unless there are other compelling clinical data to suggest the diagnosis.
In conclusion, we have reviewed all thyroid tests ordered by our pediatric gastroenterology 
office over a 5 year period, and found that only a small proportion of those we tested whose 
symptom was isolated constipation had hypothyroidism (0.2%), while those evaluated for 
constipation with slow growth or slow growth alone were much more likely to be 
hypothyroid (2.5% and 2.2%, respectively). Identifying a single case of hypothyroidism over 
this time period in a child who presented with constipation alone cost at least $18,653. 
While it might be argued that this is a reasonable price to pay, constipation alone did not 
increase the likelihood of hypothyroidism above the population prevalence for this disease.
Although there are some limitations to our analysis, our data suggest that careful 
consideration should be given when ordering free T4 and TSH concentrations in children 
with constipation without other clinical indicators of hypothyroidism. This question needs 
further investigation before these results can be applied, ideally with prospective observation 
of a large pediatric cohort.
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Figure 1. 
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